Open access
Jul 2026
Clinical genome sequencing in neurodegenerative diseases-outcome in the first 500 patients.
In FTD and ALS, these results support universal access to genetic testing independent of age at onset or family history, and provide a clear diagnostic advantage in NDDs marked by substantial clinical and genetic overlap.
Emma Ehn, H. Thonberg, Inger Nennesmo et al.
· Human Molecular Genetics · 0 citations